WBC
PTLA

Westpac Banking Corp’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Westpac Banking Corp’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-129,235
Closed -$2.32M – 859
2020
Q2 		$2.32M Buy
+129,235
New +$1.8M 0.03% 474

Westpac Banking Corp's PTLA Position: Q3 2020 in Review

Westpac Banking Corp sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 129,235 shares — an estimated $2.32M sold.

Westpac Banking Corp first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $2.32M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Westpac Banking Corp reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Westpac Banking Corp sold 129,235 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2.32M.
  • Westpac Banking Corp first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Westpac Banking Corp's Portola Pharmaceuticals, Inc. position peaked at $2.32M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Westpac Banking Corp's 13F filing for Q3 2020, filed 10 Nov 2020.